IL‐25 Disrupts the Nasal Epithelial Barrier in an Adapter Act1‐Dependent Manner

Clinical and Translational Allergy · Published 2026-03-01 · DOI 10.1002/clt2.70165

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1002/clt2.70165

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Sexual Health in Atopic Dermatitis: Impact of Skin Clinical Control · Clinical and Translational Allergy · 2025 · Same journal
• Temporal Patterns of Allergen Sensitisation in the General Population: The LEAD Study · Clinical and Translational Allergy · 2026 · Same journal
• Staphylococcus aureus and Staphylococcus lugdunensis Act in Concert to Disrupt the Nasal Epithelial Barrier · Clinical and Translational Allergy · 2026 · Same journal
• Integrated Immune, Epithelial and Lipid Pathways in NSAID‐Exacerbated Respiratory Disease · Clinical and Translational Allergy · 2026 · Same journal
• A Real‐World Cross‐Sectional Study on Suspected Mast Cell Activation Syndrome: Multiple Heterogeneous Symptoms Identified · Clinical and Translational Allergy · 2026 · Same journal
• Patient‐Reported Outcome Measures as Predictive Tools for Disease Control in Chronic Rhinosinusitis With Nasal Polyps: A Prospective Study · Clinical and Translational Allergy · 2025 · Same journal
• Unique Sensitization Patterns to Allergen Components in a Crustacean‐Allergic Australian Cohort · Clinical and Translational Allergy · 2026 · Same journal
• Paucigranulocytic Asthma in Aspirin‐Hypersensitive Patients: Pleiotropic Regulation of Type 2 Biomarkers · Clinical and Translational Allergy · 2026 · Same journal
• Between Guidelines and Daily Practice: The Persistent Use of Parenteral Depot Corticosteroids in Germany · Clinical and Translational Allergy · 2026 · Same journal
• Food Allergy Diagnosis in Early Childhood: Journey Mapping Study With Parents and Pediatricians · Clinical and Translational Allergy · 2026 · Same journal